Fr015 FACTORS RELATED TO NEW ONSET DYSPEPSIA AFTER COVID 19 INFECTION IN MEXICAN POPULATION

por Rendon, Ricardo Flores, Tellez, Francisco Alejandro Felix, Remes-Troche, Jose Maria, Gomez-Castaños, Paulo C., Coss-Adame, Enrique, Gomez-Escudero, Octavio, Avendaño-Reyes, Manuel J., Vazquez, Genaro, Velasco, Jose Antonio Velarde Ruiz, Aviles, Alex Rene Sandoval, Valdovinos-Garcia, Luis R.
Publicado 2021

Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY

por Marazzato, Massimiliano, Ceccarelli, Giancarlo, D'Ettorre, Gabriella, SANTINELLI, LETIZIA, Pinacchio, Claudia, Celani, Luigi, Cavallari, Eugenio Nelson
Publicado 2021

Fr578 ORAL TANNINS REDUCE PROINFLAMMATORY CYTOKINES ASSOCIATED WITH DIARRHEA AND PNEUMONIA IN HOSPITALIZED COVID-19 PATIENTS.

por Pisarevsky, Ana A., Mingorance, Fabiana Lopez, Vega, Patrica, Stefanolo, Juan P., Repetti, Julieta A., Ludueña, Guillermina, Pepa, Pablo D., Olmos, Juan I., Fermepin, Marcelo Rodríguez, Molino, Silvia, Uehara, Tatiana, Viciani, Elisa, Villapol, Sonia, Castagnetti, Andrea, Savidge, Tor C., Treangen, Todd J., Piskorz, Maria
Publicado 2021

Su095 REAL-TIME DEFORMABILITY CYTOMETRY (RT-DC) REVEALS NOVEL CORRELATIONS BETWEEN INFLAMMATION AND MECHANICAL PROPERTIES OF NEUTROPHILS IN IBD PATIENTS

por Ganzleben, Ingo, Müller, Hannah, Thoma, Oana-Maria, Kubánková, Markéta, Jefremow, André, Guck, Jochen, Neurath, Markus, Waldner, Maximilian
Publicado 2021

Fr304 HYPERLIPASEMIA DOES NOT CONFER WORSE CLINICAL OUTCOMES IN A RETROSPECTIVE COHORT OF NOVEL CORONAVIRUS (COVID-19) PATIENTS

por Imam, Zaid, Gill, Inayat, Antonios, Bana, Aneese, Andrew, Kakked, Guarav, Kamal, Faisal, El Kurdi, Bara, Halalau, Alexandra
Publicado 2021

Sa078 CLINICAL AND LABORATORY MARKERS DO NOT PREDICT DEEP HISTOLOGIC REMISSION IN PATIENTS WITH ULCERATIVE COLITIS

por Sharma, Disha, Choden, Tenzin, Halaseh, Ramez, Neupane, Rabin, Mattar, Mark, Malhotra, Nidhi
Publicado 2021

Sa116 A SAFETY ASSESSMENT OF THE RE-OPENING OF AN ACADEMIC MEDICAL CENTER OUTPATIENT ENDOSCOPY UNIT DURING THE COVID-19 PANDEMIC

por Manski, Scott, Schmoyer, Christopher, Pang, Alice, Lieberman, Joshua, Gernhardt, Micaela, Murugesan, Neveda, Leto, Alexandra, Erwin, Ryan, Kavanagh, Taylor R., Conn, Mitchell
Publicado 2021

Fr014 DISEASE BURDEN AND CARE-SEEKING BEHAVIOR FOR IBS-C PATIENTS IN THE UNITED STATES IN THE ERA OF COVID-19

por Lacy, Brian E., Parekh, Mousam, Taylor, Douglas C., Rooker, Ceciel, Burslem, Kate, Morlock, Robert, Morlock, Amy
Publicado 2021

Fr012 THE OBSERVED RISK OF RECURRENT BLEEDING AND THROMBOEMBOLIC DISEASE IN COVID-19 PATIENTS WITH GASTROINTESTINAL BLEEDING.

por Attah, Emmanuel O., Smith, Emily S., Martin, Tracey, Tewani, Sunena, Hajifathalian, Kaveh, Sharaiha, Reem Z., Crawford, Carl V., Wan, David W.
Publicado 2021

Sa127 AN IBD-RISK VARIANT IN PTPN2 PROMOTES CELLULAR UPTAKE OF SARS-COV-2, WHICH IS MITIGATED BY THE JAK INHIBITOR TOFACITINIB

por Spalinger, Marianne, Hai, Rong, Li, Jiang, Nordgren, Tara M., Tremblay, Michel L, Eckmann, Lars, Hanson, Elaine M., Scharl, Michael M., Wu, Xiwei, Boland, Brigid, McCole, Declan F.
Publicado 2021

Fr093 COVID-19 PEDIATRIC PATIENTS IN THE UNITED STATES; AFRICAN AMERICAN AND HISPANIC AMONG MOST HOSPITALIZED PATIENTS WITH PERSISTENT GI MANIFESTATIONS

por Ashktorab, Yusuf, Brim, Anas, Pizuorno, Antonio, Nikdel, Sahar, Gayam, Vijay, Brim, Hassan
Publicado 2021

Fr493 DISEASE ACTIVITY IS ASSOCIATED WITH COVID-19 OUTCOMES IN IBD PATIENTS WITH EFFECT MODIFICATION BY AGE

por Ricciuto, Amanda, Lamb, Christopher, Kuenzig, Ellen, Griffiths, Anne M., Kaplan, Gilaad, Walker, Gareth J., Kennedy, Nick, Benchimol, Eric, Sebastian, Shaji
Publicado 2021

Fr134 SARS-COV-2 INDUCES EPITHYELIAL-NEURONAL CROSSTALK STIMULATING VASOACTIVE INTESTINAL PEPTIDE RELEASE AS A POTENTIAL MECHANISM OF COVID-19-ASSOCIATED DIARRHEA

por He, Peijian, Tedbury, Philip, Gracz, Adam D., Mwangi, Simon M., Li, Ge, Merlin, Didier, Sarafianos, Stefan G., Srinivasan, Shanthi
Publicado 2021

18 COVID-19 AND THE GUT IN HUMAN OBESITY: OVEREXPRESSION OF SARS-COV-2 RECEPTORS REVEALED BY DEEP SINGLE CELL RNA-SEQ

por Mcrae, Alison, Silgado, Maria Laura Ricardo, Calderon, Gerardo, Izundegui, Daniel Gonzalez, Leggett, Cadman L., Simon, Vernadette, Liu, Yuanhuang, Li, Ying, Carlson, Paula, Badley, Andrew, Camilleri, Michael, Acosta, Andres
Publicado 2021

Fr006 IMPACT OF A SARS-COV2 INFECTION IN PATIENTS WITH CELIAC DISEASE

por Elli, Luca, Facciotti, Federica, Lombardo, Vincenza, Sanders, David, Vaira, Valentina, Barisani, Donatella, Vecchi, Maurizio, Costantino, Andrea, Scaramella, Lucia, Dell'Osso, Bernardo, Doneda, Luisa, Roncoroni, Leda, Scricciolo, Alice
Publicado 2021

Fr495 INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH SIGNIFICANTLY WORSENED CLINICAL OUTCOMES OF COVID-19 INFECTION IN A RETROSPECTIVE ANALYSIS OF 78,756 PATIENTS ACROSS 143 HOSPITA...

por Zackria, Rasiq, Hwang, Andrew W., Kubomoto, Scott, Heineke, Hyunju S., Ayutyanont, Napatkamon, Choi, Eric H.
Publicado 2021

Su102 DIFFERENCES IN INTESTINAL EPITHELIAL GENE EXPRESSION MODULATES SARS-COV-2 INFECTION IN HUMAN IBD ENTEROIDS

por Alvarado, David M., Castro, Maria Gomez, Sonnek, Naomi, Cui, Xueyang, Ding, Siyuan, Ciorba, Matthew A.
Publicado 2021

Fr501 BIOLOGICS AND COVID-19 OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS

por Weissman, Simcha, Aziz, Muhammad, Lee-Smith, Wade M., Elias, Sameh, Swaminath, Arun, Feuerstein, Joseph D.
Publicado 2021

Su321 DEGREE AND PATTERN OF ELEVATED HEPATOBILIARY ENZYMES ARE PROGNOSTIC OF SEVERE CLINICAL OUTCOMES IN HOSPITALIZED COVID-19 PATIENTS

por Wagner, Jason, Dupont, Andrew, Cash, Brooks D., Farooq, Ahmad
Publicado 2021

Fr402 MELD-NA SCORE VERSUS SOFA SCORE AND APACHE II SCORE AS EARLY PREDICTORS OF MORTALITY IN COVID-19 PATIENTS WITH LIVER INVOLVEMENT

por Gomez, Sandra R., Lam, Eric, Mosquera, Luis Gonzalez, Fogel, Joshua, Mustacchia, Paul
Publicado 2021